Hydrocortisone
9
2
2
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
1 terminated out of 9 trials
83.3%
-3.2% vs benchmark
11%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (9)
Corticosteroids to Treat Pancreatitis
Exploring the Effects of Corticosteroids on the Human Hippocampus
Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia
Mindfulness-based Intervention to Address PTSD in Trauma-exposed, Homeless Women
Early Versus Conventional Cessation of Hydrocortisone in Septic Shock
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
The Influence of Different Hydrocortisone Replacement Doses on the Partitioning and Flexibility of Ectopic Lipids in Patients With Corticotropic Hypopituitarism
Association Between Cortisol, Cortisone, Cotinine, Nicotine, Caffeine, Melatonin Levels in Hair, Serum, Urine, Saliva and Chronic Stress